Dose-escalated icotinib in frail, elderly patients with EGFR-mutant lung adenocarcinoma: real-world efficacy and safety in a high-risk cohort
Background The therapeutic potential of dose-escalated EGFR-TKIs in high-risk EGFR -mutant lung adenocarcinoma patients remains underexplored. This real-world study evaluated fi...